Home LiteratureArticle Details
PMID: 1696849 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Role of growth factor synthesis in the acquisition of insulin/insulin-like growth factor I independence in rat mammary carcinoma cells.

Cancer research ·Vol. 50 ·No. 17 ·1990-09-01 ·Pages 5351-7

Ethier SP, Chiodino C, Jones RF

Abstract

In previous work, we demonstrated that a subset of carcinogen-induced rat mammary carcinomas consists of cells that are independent of growth factors strictly required by normal rat mammary epithelial (RME) cells for long-term growth in serum-free medium. Furthermore, only those tumors that expressed growth factor independence in vitro were serially transplantable in vivo. The present studies were aimed at determining if the independence of insulin (IN)/insulin-like growth factor I (IGF-I) is mediated by autocrine factors synthesized by the rat mammary tumor (RMT) cells. The results of these experiments indicate that IN/IGF-I-independent RMT cells do not synthesize IGF-I that is detectable at the message or peptide level. Both normal and neoplastic cells do, however, secrete IGF-I-binding activity. Conditioned medium, cell lysates, and cell extracts obtained from growth factor-independent cells do not contain growth factor activity that can substitute for IN for growth of IN-dependent RMT cells. Growth factor-independent cells do not express a density dependence for growth in IN-free medium nor do they respond to exogenous IN or IGF-I in low density growth assays. By contrast, growth factor-dependent cells that were rendered IN/IGF-I independent by transfection with an expression vector containing the IGF-I gene secrete IGF-I-like biological activity that is readily detectable and maintain responsiveness to exogenous IN at low densities. Taken together, these results suggest that growth factor-independent RMT cells are truly autonomous of IN/IGF-I for growth and are not synthesizing a growth factor that satisfies their IN/IGF-I requirement in an autocrine manner.

MeSH Terms
Animals Cell Division/drug effects Culture Media Growth Substances/biosynthesis Insulin/pharmacology Insulin-Like Growth Factor I/genetics,metabolism,pharmacology Mammary Glands, Animal/cytology,drug effects,metabolism Mammary Neoplasms, Experimental/metabolism Poly A/genetics,isolation & purification RNA/genetics,isolation & purification RNA, Messenger Rats Receptors, Cell Surface/isolation & purification,metabolism Receptors, Somatomedin Somatomedins/pharmacology Transfection Tumor Cells, Cultured/cytology,drug effects,metabolism
Chemicals
Culture Media Growth Substances Insulin RNA, Messenger Receptors, Cell Surface Receptors, Somatomedin Somatomedins Poly A RNA Insulin-Like Growth Factor I
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Ethier S P
Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor 48109.
Chiodino C
Jones R F
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
1990-09-01
Pages
5351-7
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Grants
NCI NIH HHS · CA 40064 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com